Xiang Wang

Xiang Wang

Auto-generated profile, based on publicly available information

Xiang Wang

Guangdong Provincial Engineering and Technological Research Center for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2025 in Science Advances
Verified
Journal Article
Open access
XWXiang Wang
Xiang Wang
CSClaire Schirmer
Claire Schirmer
ETElena Totter
Elena Totter
Simone SchuerleSimone Schuerle
Simone Schuerle
Engineered skeletal muscle holds potential for tissue engineering and biohybrid robotics applications. However, current strategies face challenges in enhancing force generation while maintaining stability and scalability of the muscle, largely due to insufficient oxygenation and limited nutrient delivery. In this study, we present an engineering approach to address these limitations by coculturing Chlamydomonas reinhardtii ( C. reinhardtii ), a photosynthetic unicellular green microalga, with C2C12 myoblasts in a hydrogel matrix. Leveraging the photosynthetic activity of C. reinhardtii , our microalgae-empowered muscle (MAM) constructs exhibited superior contractility and almost three times higher active force generation compared to conventional muscle constructs. MAM showed higher cellular viability and reduced tissue damage, attributed to in situ oxygenation and nutrient supply provided by microalgal photosynthesis. In addition, improved myotube alignment was observed in MAM, which contributed to enhanced force generation. Our findings showcase the potential of photosynthetic microalgae as a functional component in engineered skeletal muscle, offering a solution to longstanding challenges in muscle engineering.

16 October 2023 in Biomaterials Science
Verified
Journal Article
Open access
PDF file
DADaphne Osk Asgeirsson
Daphne Osk Asgeirsson
AMAvni Mehta
Avni Mehta
ASAnna Scheeder
Anna Scheeder
FLFan Li
Fan Li
XWXiang Wang
Xiang Wang
Simone SchuerleSimone Schuerle
Simone Schuerle
Effects of magnetically controlled cyclic deformation on cancer cell invasion.

1 June 2026 in Materials Today Bio
Verified
Journal Article
Open access
TSTao Sun
Tao Sun
XWXiang Wang
Xiang Wang
YJYawen Jiang
Yawen Jiang
MLMingxiu Liu
Mingxiu Liu
LHLianting Huang
Lianting Huang
WXWei Xue
Wei Xue
Cancer treatment remains a critical global health challenge, which often requires multimodal and targeted therapeutic strategies, yet integrating these modalities typically demands complex formulations. Oncolytic bacterial therapy offers unique opportunities for targeted drug delivery and immune modulation, yet clinical translation has been hindered by safety concerns and tedious engineering modification. Here, we report a deformable Bacillus subtilis (DBS), constructed through one-step cisplatin-induced morphological transformation that elongates the bacterium while simultaneously incorporating chemotherapeutic payloads. The resulting DBS integrated three synergistic antitumor mechanisms: Chemotherapy, Starvation, and Immunotherapy. Metabolically, DBS actively consumes glucose and lactate within the tumor microenvironment (TME), thereby depriving tumor cells of key nutrients and reshaping the microenvironment to become more permissive to therapy. Concurrently, anaerobe-targeting DBS releases the encapsulated cisplatin locally in the TME, enabling direct cytotoxic killing while limiting systemic exposure. Furthermore, DBS leverages its intrinsic immunogenicity to potentiate immune cell activation, while its elongated morphology prolongs tumor retention and facilitates enhanced interactions with infiltrating immune cells. Proteases secreted by DBS hydrolyze the extracellular matrix, facilitating immune cell infiltration and boosting anti-tumor immune responses. Surprisingly, DBS exhibits intestinal homing and is safely cleared through fecal excretion after treatment, minimizing systemic side effects. This study presents an efficient and safe live-bacterial platform for cancer therapy, underscoring the broad potential of bacterial morphology engineering as a facile strategy to integrate multiple synergistic antitumor mechanisms within a single microbial therapeutic.